Vaxcyte, Inc. (PCVX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Vaxcyte, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.19x | -21.53x | -15.17x | -13.92x | -12.34x | -8.80x |
| P/B Ratio | 2.34x | 3.02x | 4.92x | 3.26x | 4.35x | 2.27x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 7.91x | 12.75x | 7.54x | 23.26x | 8.93x | 8.30x |
| Quick Ratio | 7.91x | 12.75x | 7.54x | 23.26x | 8.93x | 8.30x |
| Leverage | ||||||
| Debt/Equity | 0.09x | 0.02x | 0.02x | 0.02x | 0.06x | 0.00x |
YoY = year-over-year change. Source: FMP..